Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cencora Inc (NY: COR ) 223.43 -1.92 (-0.85%) Official Closing Price Updated: 7:00 PM EDT, Sep 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Cencora Inc Cencora Elects Frank Clyburn to Its Board of Directors August 15, 2024 From Cencora Via Business Wire Cencora Announces Common Share Repurchase From Walgreens Boots Alliance August 01, 2024 From Cencora Via Business Wire Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds August 01, 2024 From Walgreens Boots Alliance Via Business Wire Cencora Reports Fiscal 2024 Third Quarter Results July 31, 2024 From Cencora Via Business Wire Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release July 05, 2024 From Cencora Via Business Wire Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance May 22, 2024 From Cencora Via Business Wire Cencora Reports Fiscal 2024 Second Quarter Results May 01, 2024 From Cencora Via Business Wire Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release April 05, 2024 From Cencora Via Business Wire Cencora Announces Leadership Succession Plan March 12, 2024 From Cencora Via Business Wire Cencora Announces Common Share Repurchase From Walgreens Boots Alliance February 07, 2024 From Cencora Via Business Wire Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds February 07, 2024 From Walgreens Boots Alliance Via Business Wire Cencora Closes $500 Million Senior Notes Offering February 07, 2024 From Cencora Via Business Wire Cencora Prices $500 Million 5.125% Senior Notes Due 2034 February 05, 2024 From Cencora Via Business Wire Cencora Reports Fiscal 2024 First Quarter Results January 31, 2024 From Cencora Via Business Wire Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release January 04, 2024 From Cencora Via Business Wire Teva Pharma is the way to play the re-rise of generic drugs November 28, 2023 Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth Via MarketBeat Cencora Announces Common Share Repurchase From Walgreens Boots Alliance November 09, 2023 From Cencora Via Business Wire Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results November 02, 2023 From Cencora Via Business Wire Eli Lilly, McKesson, Novartis Flash Promising Chart Action October 09, 2023 Eli Lilly, McKesson, and Novartis are catching investors' attention with promising chart patterns and revenue growth, signaling potential buying opportunities. Via MarketBeat Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release October 02, 2023 From Cencora Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.